Ayala Pharmaceuticals Presents Positive Interim Data from RINGSIDE Pivotal Phase 2/3 Trial of AL102 in Desmoid Tumors at ESMO Congress 2022

REHOVOT, Israel & WILMINGTON Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers today announces updated, positive interim results from Part A of the ongoing RINGSIDE Pivotal

More

5 Important Facts About Flipper Teeth

They say “Smile while you still have teeth’; we say “Never let your smile fade, if you lose your teeth, get new ones!  Gum disease, cavity, physical injury or trauma, and a range of other diseases; there are so many

More